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Abstract 
 
 
The value of patient education has been widely documented in various patient 
populations.  The main focus of this study is to evaluate the timing of patient education in 
correlation with the time since diagnosis.  The goal of this study is to make recommendations for 
the optimal time in which patient education should be delivered following a diagnosis of 
Multiple Sclerosis (MS).   This study evaluates self-advocacy using the Patient Self-Advocacy 
Scale (PSAS) which was completed pre and post educational programs.  This data, combined 
with demographic data was analyzed for any relationships.  Although no statistically significant 
findings were established, many important trends in data were noted which support the need for 
patient education.   
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CHAPTER 1: INTRODUCTION  
Introduction and Background 
Recent research has shown the benefits of a multidisciplinary approach to the 
treatment of Multiple Sclerosis (MS).  (Burks, 2000; Halper, 2010; Namey, 2010).  This 
includes many new treatment options including disease-modifying medications.    
However, many patients live in areas with limited access to care, are not provided with 
appropriate information to effectively self-advocate in disease management. There is no 
current standard regarding the optimal amount and timing of disease information 
provided to patients after receiving a diagnosis of Multiple Sclerosis.   
 Treatment of MS includes medication management and monitoring of disease 
progression by a physician or nurse practitioner.  There is also a significant amount of 
research supporting the benefits of a multidisciplinary approach to MS management, 
including nursing, rehabilitation experts, social workers, nutritionists and mental health 
practitioners, and others.  Due to the wide range of clinicians involved in care, there is 
potential for education to be completed in various settings and depending on the 
healthcare system, there may be little to no communication between providers.  The goal 
of this research is to standardize the timing of education provided to patients newly 
diagnosed with MS to maximize their ability to act as their own advocates for healthcare 
needs.  
 One of the challenges of caring for people with MS in less populated areas is the 
lack of access to healthcare specialists.  In some instances, a general neurologist or 
physical therapist may provide patient care instead of providers with specialized training 
in the management of patients with MS.  There is a growing trend of larger healthcare 
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systems to guide patients towards specialists to optimize care.  In these larger systems, 
there are often resources available to support medical care through support groups, 
exercise programs, educational programs and access to a wider variety of medical 
professionals.  One strategy for supporting the medical treatment of MS is to offer 
educational programs provided by a variety of clinical specialists.    
 Many larger healthcare systems have access to expert clinicians of varying 
specialties of care to provide patient education.  A common model is for routine 
educational programs to be offered for newly diagnosed patients with MS.  Depending on 
when patients are diagnosed and/or their availability to attend, there is variable timing for 
when these classes might take place.  In one healthcare system, a four-hour educational 
program titled “MS 101” is offered quarterly.  The neurologist encourages patients to 
attend the next available course following a definitive diagnosis of MS.  However, 
depending on the timing and patient availability, several months or years may pass before 
the patient might attend this program.  In other cases, patients may attend a session the 
first week they are diagnosed, when the news is still very novel.   
 A current model for this educational program includes information from social 
workers, nurses and mental health professionals.  The medical team is introduced, 
resources available to patients are presented and discussions about disease progression, 
including the disability process and mobility options are addressed.  Depending on the 
patients’ attitude, this information may be overwhelming or depressing, or patients may 
feel that some of this information may negatively impact their future outlook.  Other 
individuals may receive this information and process it all, and may find most of it 
relevant to their individual needs.  
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Statement of the Problem 
 The problems related to education in patients with Multiple Sclerosis are multi-
factorial.  The first challenge is the potential for patients to be overwhelmed with new 
information shortly after being diagnosed with this progressive neurologic condition.  
The second problem is that if patients are not educated in a timely manner, they may have 
low self-efficacy, autonomy and ability to advocate for personal needs.  This may lead to 
limited ability to participate in treatment decisions based on those needs.  In modern day 
healthcare systems, there is increased need for patients to be active participants with 
health care providers in decision making related to the care of their condition.  Poor 
timing of education can potentially impact a patient’s self-efficacy as well.  If education 
is not quickly received patients may be ineffective in self advocacy.  Conversely, 
providing too much education too quickly may overwhelm patients with information. 
Purpose of the Study 
 The purpose of this study is to determine the appropriate amount and timing of 
education to patients that are newly diagnosed with Multiple Sclerosis to maximize self-
efficacy.  The goal is to determine patient cognitive load after receiving a diagnosis of a 
progressive neurological condition and tailor educational programs to best meet patient 
needs.   An additional purpose is to identify the patient’s perceived ability to act as their 
own advocate following diagnoses of a progressive neurologic condition.  
Research Questions/Hypotheses  
Research Question 1: How does the timing of patient education affect self-advocacy in 
patients with MS?   
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Research Question 2: How does the amount of information provided to patients with MS 
impact their self-advocacy?   
Research Question 3: What demographic information correlates with self-advocacy? 
Research Question 4:What are the optimal time frames in which diagnosis education 
should occur?  
Research Question 5: How much information can patients with a progressive neurologic 
condition absorb in the acute phase of diagnosis? 
Hypotheses 
H1 (Null): There is no relationship between the timing of education and patient self-
advocacy. 
H1 (Alternate): There is a relationship between the timing of education and patient self-
advocacy.  
H2 (Null): The amount of education has no impact on self-advocacy. 
H2 (Alternate): The amount of education provided negatively impacts self-advocacy. 
H3 (Null): There is no correlation between demographics and patient reported self-
advocacy. 
H 3 (Alternate): There is a correlation between demographics and patient reported self-
advocacy. 
H4 (Null):  There is no correlation between timing of patient education and self-
advocacy.   
H4 (Alternate):  There is a correlation between the timing of patient education delivery 
and self-advocacy. 
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H5 (Null):  There is no relationship between the amount of information provided to 
patients and reported self-advocacy. 
H5 (Alternate):  There is a relationship between the amount of information provided to 
patients and reported self-advocacy.   
My hypothesis is when provided with four hours of education close to the time of 
diagnosis (less than 2 months), patient retention and self-efficacy will be poor.  I also 
believe demographic data contributes to the self-efficacy of patients with Multiple 
Sclerosis.  
Significance of the Study 
 The goal of this study is to determine how much education should be provided to 
newly diagnosed patients with Multiple Sclerosis and when that information should be 
provided.  Clinical observation and the literature have shown that there is a wide variety 
of educational models for individuals with MS.  Patients are educated at varying points 
after receiving the diagnosis and this may impact the ability to effectively self-advocate. 
Self-advocacy has been well studied in cancer, mental illness and AIDS patients and has 
been shown to positively affect the quality of care patients receive.  (Brashers et. al, 
1999; Jonikas et. al, 2013; National Mental Health Clearinghouse).  This study should 
offer guidelines on the optimal amount and timing to provide the information to patients 
about MS and treatment options.  By improving these factors, patients should more 
effectively advocate for themselves, obtain better care and outcomes with improved 
quality of life.  There is potential to standardize this information throughout MS centers 
to better educate and optimally treat these patients.   
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 Research studies have shown that patient education programs provided in acute 
care settings lead to decreased readmission rates and decreased follow-up visits to 
emergency rooms, suggesting a decrease in overall healthcare costs.  (Jack et. al, 2009).  
Assumptions & Limitations 
 In this research, it is assumed that patients with Multiple Sclerosis who choose to 
attend educational program after a diagnosis are motivated to better advocate and to 
participate in decision making related to treatment.  It is assumed that participants in the 
MS 101 courses will provide accurate demographic information and healthcare 
professionals that lead the course are sufficiently trained and considered to be experts in 
the area of Multiple Sclerosis.   
 There are limitations to this study, including patient willingness to participate in 
MS 101.   The dates, times, and locations of the course, as well as personal motivation 
may affect patient participation.  Three MS 101 courses will be used for analysis and will 
take place on different days and different times of day.    Additional limitations may be 
accurate reporting from participants completing pre and posttest information and the 
analysis of education programs is from three courses provided only at Norton Healthcare 
in Louisville, KY.    
Nature/Organization of the Study 
 Patients who choose to participate in the MS 101 courses offered in the second 
half of 2016 will be asked to provide demographic data and the date of MS diagnosis.  
They will complete a pre-course Patient Self-Advocacy Scale (PSAS).  The study will 
categorize patients based on elapsed time since diagnosis and compare self-efficacy 
scores before and after the educational program, MS 101.   An ANOVA comparison will  
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compare patients in various timeframes since diagnosis and scores on their self-efficacy 
outcomes.   
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CHAPTER 2 – LITERATURE REVIEW  
Introduction 
Multiple Sclerosis (MS) is a chronic and progressive disease affecting the central 
nervous system.  As an immune-mediated disorder in which the immune system destroys 
myelin, the protective sheath around nerves, MS results in slowed conduction of nerve 
signals and manifests itself in a wide variety of clinical presentations.  Currently, there 
are about 400,000 individuals living with MS in the United States.  Typically, the onset 
of symptoms occurs between ages 20-40, affects women more than men, and has no 
significant impact on life-span.  MS symptoms are highly variable from person to person; 
common signs and symptoms may include optic neuritis, weakness, paresthesias, pain, 
fatigue, cognitive impairments or balance deficits.   Optic neuritis is an inflammatory 
process of the optic nerve that presents as unilateral eye pain or vision problems, usually 
occurring early on in the disease process.  Paresthesias are a common initial symptom of 
MS, presenting as numbness, tingling or atypical pain throughout the body.  The National 
MS Society estimates that at least half of all patients with MS will develop cognitive 
impairments at some point.  There are several possible presentations including 
impairments in memory, attention, information processing, decision-making and word 
finding.  Memory impairments typically affect short-term memory or the ability to recall 
things for brief periods of time, while long term memory is generally unaffected.  
Impairments in information processing typically affect the ability to interpret information 
gathered through verbal, visual or sensory delivery.  Currently, there is no specific 
diagnostic test for MS, but a diagnosis is generally made by a neurologist’ s interpretation 
of magnetic-resonance imaging (MRI) results, lumbar puncture to test for presence of 
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oligoclonal bands in the cerebrospinal fluid, and possibly nerve-conduction velocity 
testing.   
Currently, there is also no cure for MS.  Instead the disease is managed through 
disease-modifying therapies (DMTs), a class of drugs new to the market in the past two 
decades, which are designed to slow disease progression.  DMTs and serial imaging are 
managed in most cases by a neurologist, but there is significant need for a multi-
disciplinary approach to care for patients with MS.  Ideally, the treatment team should 
include the neurologist and neurologic nurse practitioner, a registered nurse (RN) that 
specializes in the management of MS, mental health providers, social workers and a 
rehabilitation team including physical, occupational and speech therapists.  Halper (2010) 
defined the importance of an MS nurse to facilitate patient education including 
information about the diagnosis, treatments, and access to resources.  Gallien et. al. 
(2014) has described the value of multidisciplinary care models to treat MS given the 
complexity of the disease.   This paper discussed the role of neuropsychology including 
cognitive and psychological impairments that should be treated in collaboration with 
psychiatry, psychology, and speech therapy to comprehensively address the impairments 
from both medical and non-medical approaches.  A similar model for pain management 
was suggested including rehabilitation professionals, nursing, pharmacotherapy, and 
medical management.   
There are four major classifications of MS according to the National MS Society: 
relapsing-remitting, primary progressive, secondary progressive and progressive-
relapsing.  Relapsing-remitting is the most common form of MS affecting about 85% of 
patients and is characterized by periods of active inflammation and demyelination in the 
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CNS followed by periods of remission or stability of the disease.  Primary progressive 
MS is defined as worsening neurologic function from the time of diagnosis with or 
without relapses and remissions.  This form of MS affects about 15% of patients.  
(National MS Society).  Secondary progressive MS (SPMS) typically begins as a 
relapsing-remitting course and transitions to SPMS when there is progressive worsening 
or neurologic decline over time.  Patients with SPMS may experience worsening of 
neurologic function even during times where there is no active inflammatory process or 
demyelination occurring.  Progressive-relapsing MS is characterized by a steady decline 
in function from the time of diagnosis with occasional periods of relapse and is 
considered to be a form of primary progressive MS.  (Halper, 2010; National MS 
Society).   
MS is typically managed with disease-modifying therapies (DMTs) to decrease 
the frequency and intensity of exacerbations or active inflammatory processes that result 
in demyelination of nerves.  Once a neurologist has confirmed a diagnosis of MS, they 
select the DMTs that are most appropriate for that patient based on potential side effects 
and risks associated with each drug.  Routine MRI studies and clinical examinations by a 
neurologist are utilized to assess for disease progression including MRI changes 
indicating active demyelination or clinical worsening of symptoms or patient 
presentation.  In the event of MRI changes or clinical progression, a neurologist can 
determine if the patient is having a suboptimal response to their DMT and whether the 
medication should be altered.   Adjunct medical therapies may be indicated for symptom 
management including spasticity control, bowel and bladder dysfunction, fatigue, sleep 
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disorders or pain.  The neurologist also facilitates referral to other healthcare providers 
for additional support in management of MS.   
The Multiple Sclerosis Association, Multiple Sclerosis Society and local chapters 
or centers are a primary source of information and resources for people with MS.  These 
organizations offer information on a variety of topics related to MS, and often host live 
seminars or educational programs related to the disease.  Kieseier (2015) discussed the 
dynamic nature of MS and the evolving treatments available as disease-modifiers or 
adjunctive therapies, stressing the importance of education of patients and healthcare 
providers.     
Patient Education 
The need for lifelong management of progressive neurologic diseases such as MS have been well 
Described. (Feicke, 2014, Gallien et. al., 2014; Halper, 2010; Kieseier, 2015; Matti et.al. 
2010.)  Treatment approaches to MS have changed significantly over the past several 
years.  (Kiesier, 2015)   The past two decades have allowed for development of thirteen 
Food and Drug Administration (FDA) approved DMTs as well as improved magnetic-
resonance imaging (MRI) techniques to monitor disease progression.  Additionally, 
public understanding of the nature and management of progressive neurologic diseases 
has increased recently.   
 Gallien et. al. (2014) described the importance of treatment of individuals with MS being  
multimodal and interdisciplinary.  This study delineates the importance of a collaborative 
team of neurologists, physical therapists, occupational therapists, speech language 
pathologists and other healthcare providers in the management and treatment of the 
person with MS.   However, it may be important to educate patients on the expertise of 
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each provider in order to clearly express their needs to the appropriate provider.  There 
are many studies that highlight the effectiveness of educational programs in management 
and compliance of treatment in progressive conditions.  (Fraser, 2009; Holman 2004).  
Bishop and Frain (2007, 2011) have identified five components of MS-specific self-
management abilities.  These dimensions include treatment adherence and barriers, 
understanding and actively learning about MS, managing one’s health, being an active 
participant in decision making, and managing the impact of MS on life. These 
components are based on the foundational education that was provided to individuals at 
or near the time of diagnosis.  Patients must first receive education on MS and various 
treatment options available to become active participants in the decision making process. 
Furthermore, all of these components are addressed in the MS 101 program to assess the 
correlation between MS education and self-efficacy.   
Kopke et. al. (2009) studied the relationship between patient autonomy and 
management of relapses in MS.  In this study, 150 people with relapsing-remitting MS 
were provided education about their disease in a structured group format after being 
provided with written educational materials prior to attending the course.  The 
educational information provided data on the option of oral corticosteroid or 3-day high 
dose intravenous steroids in the event of an acute relapse.  The control group received 
educational materials regarding only disease relapse and the use of corticosteroids 
therapies. Participants were followed for two years with periodic phone calls to inquire 
about relapses.  The authors concluded that the structured educational program had a 
significant impact on patient decision-making ability and autonomy when it came to the 
treatment of acute relapses of their MS.  The structured education focused on recognition 
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of an actual relapse compared to possible pseudo-relapse and when to contact a physician 
for assistance.  Patients that received the structured educational information were less 
likely to pursue the use of steroids and were more cautious in their use of these drugs.  
Patients were followed for two years, and there were no significant differences between 
groups for quality of life or disability statues. In this study, structured educational 
interventions were associated with improved management of relapses, decreased use of 
steroids and overall improved autonomy.  (Kopke, 2009).  The limitations of this study 
include the lack of blinding of outcome evaluators, which potentially could have biased 
participant’s decisions.  Additionally, there were no clinic visits to discuss relapse 
treatment, physicians were blinded to allocation of each patient, and there was no ability 
for investigators to assess time between acute relapse and initiation of treatment as a 
component of autonomy.  There are several strengths to this study including well 
researched outcome measures, recruitment via media to generalize the population and 
education provided by specially trained nurses or patients with MS to standardize 
information and make the study transferrable to other populations.  
  The Center for Advancing Health (2014) has defined patient engagement as the 
efforts to maximize the benefits of the healthcare services to which they have access.  
Historically, individuals with MS had limited treatment options and DMTs had side 
effects and risks.  More recently, additional DMTs have been approved and now 13 such 
treatment options exist.  The addition of new DMTs has offered improved efficacy in 
disease control but has also have increased side effects.  Newer drugs have improved 
ability to decrease the frequency and intensity of demyelinating and inflammatory 
attacks, but increased drug efficacy means greater risk.  This intensifies the need for 
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patient education on treatment options and medication risks.  (Center for Advancing 
Health, 2014).   
Bjornevik et. al. (2016) investigated the association between educational level and 
risk of MS in a study comparing 953 patients with confirmed MS to 1717 healthy 
controls. Norweigians were studied to eliminate geographical variations since this is a 
known risk factor for MS.  Subjects completed surveys about their educational level and 
covariates of other known risk factors: smoking, exposure to mononucleosis, vitamin D 
levels or sun exposure and body size.  There were significant correlations between risk 
factors and level of education. Patients with lower levels of education were more likely to 
spend more time outdoors as an adolescent or be smokers.  In this sample, there was a 
statistically significant association between lower levels of education and risk of MS.  
The limitations of this study included the presence of non-responders, which indicates 
possible selection bias and surveys asking for recall of exposure to risk factors as 
adolescents.   
Bishop et. al. (2009) recognized that people who are diagnosed with a 
neurological condition are likely to seek out information from various sources to educate 
themselves about their condition and the future.  The goal of this research was to identify 
the most common tools patients utilize to gain information and therefore assist in making 
recommendations on delivery of information and providing feedback to patients on how 
best to access information.  (Bishop, 2009).  As part of a larger project, surveys were 
mailed to 1000 people with MS with 409 returned for analysis.  Respondents identified 
the places they sought information from the most: internet, books or print, physicians, 
support groups, local or national MS groups or other. Their findings showed that 
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physicians (31.69%), the internet (27.94%) and local or national MS agencies (21.64%) 
were the most popular sources of information. (Bishop, 2009).  A limitation of this study 
was physician sources of information did not specify physician specialty, suggesting that 
respondents may utilize primary care physicians or non-specialists, leading to limited or 
erroneous information.  This implies the need for educational delivery in a group setting 
to be delivered by the most qualified provider providers to ensure evidence-based 
treatment options.  Furthermore, reliance on the internet leads to concerns of quality and 
accuracy of information.  When provided the opportunity, healthcare professionals can 
steer patients towards optimal internet resources to ensure accuracy.  Lastly, the group 
setting may be beneficial in establishing relationships early with supporting healthcare 
providers such as therapists, mental health professionals and nurses who may have 
expertise in the treatment of people with MS.  An additional limitation of this work was 
the likelihood of potential barriers to learning (vision, cognitive impairments) that may 
limited educational options.  (Bishop, 2009).   
Somerset et. al. (2001) reported that patients who sought and gained access to 
information about their MS were more likely to have higher quality of life, improved 
psychosocial factors and decreased need for feedback or interaction with healthcare 
professionals.  Johnson (2003) proposed that information provided at or near the time of 
diagnosis allowed patients to formulate opinions that may have a lasting effect on the 
perception of disease progression.   Furthermore, access to critical information on 
prognosis, treatment, research opportunities, healthy lifestyle and patient rights was 
associated with improved ability to communicate needs and participate in treatment 
decision-making.  (Bishop, 2009). 
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Matti et. al. (2010) investigated the various types and volume of information 
consumed by newly diagnosed patients with MS in Australia.  This research followed up 
on several studies that had shown people wanted more information than they received 
from providers and expressed concerns about access to reliable source for information 
and education.  (Forbes et. al, 2007).  Forbes et. al. (2007) specifically defined that 
educational needs were the highest early in the disease process, suggesting this was a 
critical time for patient education. Matti et. al. (2010) had 23 patients newly diagnosed 
with MS attend an educational program about the disease and participate in data 
collection.  These 23 patients completed questionnaires over a nine-month period and 
reported on the volume of information received from physicians, educational programs, 
MS nurses, and the internet.  In this study, the Multiple Sclerosis Society of South 
Australia and MS specialist nurses provided the most appropriate amounts of information 
after the diagnosis of MS and confirmed the correlation between of the amount of 
information received and the professional providing the information.  Responders 
identified the MS Society of South Australia was the most preferred and relevant 
provider of information.  However, patients specifically wanted more information on 
topics including the symptoms of MS, disease prognosis and disease management.  This 
study reported similar findings to the work of Somerset et. al. (2002)  who found that 
patients in their study also preferred education from nurses with specialized MS training 
or certifications.   Matti also reported that primary care physicians provided the least 
relevant and smallest volume of information and confirmed the biggest need for patient 
education was related to symptoms management.  (Matti, et. al. 2010). 
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Somerset et. al. (2001) surveyed 318 people with MS in Scotland and England 
who responded to a questionnaire determining patient needs and expectations related to 
healthcare services.  The findings showed that 41% of patients wanted more feedback or 
advice related to exercise, 33% desired additional information on diet and 25% requested 
additional information on medications or alternative treatments. Additional data was 
collected on frequency of healthcare visits within the past year.  Few patients (39%) 
reported having a consult with a physical therapist in the past year, suggesting a lack of 
formal education or information provided on exercise.  Only 16% of respondents reported 
contact with an MS nurse specialist, but about 30% of patients reported that they wanted 
that interaction.  Additionally, respondents completed the Short-Form 36 (SF-36) which 
showed poor self-reports health in almost every area except physical function.  
Furthermore, respondent SF-36 scores indicated poor health status or quality of life when 
compared to healthy individuals.  One of the primary limitations of this study was that 
some general practitioners requested their patients not participate in the survey-based 
study. (Somerset, 2001). Somerset also described their study limitations to include the 
general vagueness of surveys that do not allow for patient commentary.  (Somerset, 
2001).   
Box et. al. (2003) surveyed 2030 people with MS to compare education received 
with diagnosis year.  In 1974 only 14% of patients diagnosed reported receiving formal 
education.  By 1990, this number had improved to 34% and in 2000 72% of patients were 
provided with education about the disease.  However, 28% of those diagnosed received 
no formal education.  Additionally, patients reported that the top five areas of education 
they most desired at the time of diagnosis were: MS symptoms, symptom management, 
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medications, disease course and contact with an MS certified nurse.  The biggest gap in 
education found by this study was the management of MS symptoms.  (Box, 2003) 
Box et. al. (2003) also surveyed patients to rate the level accessing information 
about MS and approaches to treatment.  Patients were asked to rate each survey item on a 
five point scale ranging from “not difficult at all” to “very difficult.”  Over 40% of 
respondents reported that finding access to clinical trials, information about drugs, 
emotional changes and new symptoms were difficult or very difficult to access.  Patients 
also responded that their preferred method of educational delivery for this information 
would be via face-to-face contact with healthcare professionals, MS experts or through 
leaflets.  (Box, 2003). 
Heesen et. al. (2007) defined the importance of shared decision making (SDM) in 
the management of MS.  The value of the SDM is the “two-way exchange of information 
between physician and patient.”  (Heesen, 2007; pg. 117).  In this model, the physician is 
able to apply evidence-based practice and the patient can offer personal experience and 
perspectives on disease process and impairments.  The study included 100 randomly 
selected patients with primary-progressive MS from a database of over 1300 patients. Of 
the 200 people contacted, 169 responded to questions about decisional role preferences, 
MS risk knowledge and informational interests and preferences. Findings confirmed that 
79% of participants preferred active decision-making roles. The survey also reported 
information interest areas were treatment of symptoms (specifically gait impairments and 
physical therapy), use of magnetic resonance imaging (MRI) information related to 
relapses and complementary medication options.  Furthermore, Hessen et. al. correlated 
information interest to type of MS.  MRI use was highest for patients with a relapsing-
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remitting course, while patients with primary-progressive MS were most interested in gait 
changes and physical therapy.  Limitations in the SDM model were some patients did not 
want active decision-making roles and preferred the physician make critical decisions.  
Trust between the patient and physician and the ability for both to work together to 
maximize outcomes were other potential areas of concern.   (Heesen et. al., 2007).   
Baker (1998) interviewed 13 patients to collect data on MS exacerbation 
experiences.  The interviewees ranged from 32 to 56 years of age, included 10 women 
and 3 men with MS histories between 1.75 years to 17 years.  Baker studied the 
knowledge gaps, questions, answer strategies and information barriers the patients had 
during exacerbations.  Data was collected in 1-2 hour recorded interviews for 
exacerbation specific events over the course of the patient’s disease.  The subjects 
selected 39 events for further investigation and opportunities to ask professionals about 
the nature of the symptoms experienced during an attack.  Interviewers identified three 
gaps in patient education: the physical symptoms experienced, emotions experienced and 
lack of information about medications received during attacks.   Not all patients sought 
out information to answer questions during exacerbations, some reported reading material 
was helpful, while some reported discussions with healthcare professionals were 
beneficial.  Patients reported confirmation of symptoms and the course of exacerbations 
as helpful.  Barriers to obtaining information were lack of up-to-date resources, generic 
information that did not address specific situations and symptom denial limited the 
pursuit of medical attention.  Limitations in this study include the small sample size and 
the interview strategy that allowed for analysis of multiple attack events.   
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 Bombardier et. al. (2005) defined health promotion as activities capable of 
improving the general well-bring of patients, and potentially improving physical, social 
and emotional health.  Challenges of health promotion is the lack of provider time with 
each patient, access to patient resources and funding issues.  Also described was the 
importance of patient responsibility to advocate for needs and participation in decisions 
related to care.  Bombardier et. al. described popular areas of self-advocacy as exercise, 
stress management, social support, compliance with prescribed therapies and nutrition.   
Chiovetti (2006) has referenced many studies that describe the high volume of 
information that is required following a diagnosis of MS and the overwhelming nature of 
this process.  The author also described the importance of timing information delivery 
with the management of MS, citing that “providing patients with appropriate and timely 
information is a key component of MS care.”  (Chiovetti, 2006 pg. 374).  Health literacy 
is an important aspect of patient education, which is the degree in which patients are able 
to obtain, process, and understand health information or resources to make decisions 
about healthcare needs.  Effective health literacy requires that patient education be 
modified to accommodate all levels of education and learning.  Otherwise, patients with 
lower education or literacy levels may not comprehend or misinterpret information, 
which could lead to unmet healthcare needs and poorer disease management.   
Chiovetti (2006) described barriers to learning in the healthcare setting, including 
cognitive or visual impairments and varying educational level need.  The author further 
discusses the role of nurses with experience in MS as playing key roles in patient 
education.  Furthermore, the author recommended education should occur in friendly 
environments where patients are not distracted or feel rushed.     Chiovetti also 
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recommended that education be provided in multiple forms – written and verbal, and 
should generally occur at appropriate levels for the general population.   
Education is a critical component of chronic disease management and should be 
provided to all patients.  There are many possible delivery methods for education 
including websites and blogs.  For adequate education to occur, patients must have access 
to educational programs and be able to understand and absorb the information being 
provided.  There are also many barriers to education, specific to people with MS 
including access to resources such as the internet or specialists, access to quality 
educational programs led by experts in MS care and cognitive or psychological 
impairments affecting patient’s ability to advocate for themselves or manage their 
disease.    Patients may also struggle to identify when to contact healthcare providers and 
the responsibilities of each provider.  There are many factors to be considered by the 
patient and their family or caregivers at the time of diagnosis, including accepting the 
implications of a chronic neurological disease.  Patients may be overwhelmed with 
information provided about a disease they have not yet accepted.  Additional barriers to 
education include lack of access to educational programs or the internet, which is a 
popular method of information-gathering.  One of the major values of patient education is 
that it allows patients to be empowered to be their own advocate and participate in 
decision-making related to their healthcare needs.  
In recent years, the internet has become one of the most popular vehicles of 
information for patients.  Synnot et. al. (2014) reported that many patients utilize the 
internet as a primary means to gain information about their diagnosis, but that many 
patients report difficulty understanding information provided on websites.  Synnot et. al. 
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also reported that some of the most commonly utilized websites for patients to gain 
information have low readability levels, which likely leaves patients with unanswered 
questions or inadequate information.  (Synnot, et. al. 2015).  
Self-Efficacy & Advocacy 
The National Mental Health Consumer’s Self-Help Clearinghouse “Technical 
Assistance Guide to Self-Advocacy” defines attitudes and abilities required for self-
advocacy development.  Two attitudes recommended for patients who wish to advocate 
for themselves is to believe in themselves and be assertive. The Clearinghouse Guide also 
discusses the importance of education, further citing the importance of early education 
instead of reactive educational strategies.  Although geared towards mental health, 
patients with MS may also avoid information until a problem arises, which could delay 
getting immediate information during an acute relapse.  According to the Clearinghouse 
recommendations, patients should educate themselves early and create their own 
individualized set of accessible resources.  Patients need to approach education from 
every viewpoint and then tease out information that is specific to personal needs. 
(National Mental Health Consumers’ Self-Help Clearinghouse). 
 Self-advocacy promotes the importance of patients breaking down a problem and 
determining the most important part and taking action, according to the National Mental 
Health Clearinghouse.  Section 3 will further discuss how people with MS may have 
impairments that prevent them from identifying the most important part of a problem or 
recognizing what parts of the problem that can be impacted.  (National Mental Health 
Consumers’ Self-Help Clearinghouse).  
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Bandura’s work has defined the necessity of self-efficacy in management of 
disease and in overall psychosocial function.  (Bandura, 1977) Furthermore, Bandura 
defines self-efficacy as an individual’s beliefs about their ability to achieve the desired 
outcome.  (Hughes, 2015).  This concept has been studied in multiple patient populations, 
including spinal cord injury epilepsy and diabetes.  (Hughes, 2015)  Research with 
various patient populations has indicated that self-efficacy is modifiable and highly 
associated with functional outcomes and improved quality of life.  (Aalto, 1997; 
Tsaousides, 2009)  Studies that have assessed interventions designed to improve self-
efficacy have shown improvements in chronic disease management.  (Aalto, 1997; 
Northern, 2001). 
Wilski and Tasiemski (2015) identified the relationships between treatment 
beliefs, illness perception, self-esteem and self-efficacy and self-management of multiple 
sclerosis.  In surveys of 210 people with MS, specific factors related to self-management 
were identified using multiple tools to identify personal factors that related to self-
management of the disease.  In this study, the following tools were used: self-
management was assessed using the Multiple Sclerosis Self-management Scale – 
Revised; illness perception was rated using the Brief Illness Perception Questionnaire; 
self-efficacy was measured with the Generalized Self-Efficacy Scale; and self-esteem 
was measures with the Rosenberg Self-Esteem Scale.  The test-retest reliability, 
predictive validity and concurrent validity of this tool were established by Broadbent et. 
al. (2006).  The research found women with MS had higher reported self-management 
skills than men with MS and that individuals with higher education levels had higher self-
management scores.  An important finding in this study was there is no significant 
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correlation between Expanded Disability Status Scale (EDSS) and self-management.  
Wilski and Tasiemski (2015) found that younger patients had higher scores on self-
management outcomes.  
The EDSS is a 10-item ordinal scale reporting overall disability in MS.  The scale 
ranges from 0 (normal neurologic function) to 10 (death from MS) and is reported in 
half-point increments.  The EDSS is geared towards ambulation, reporting heavily on use 
of assistive devices or wheelchairs.  (Kurtzke, 1961; Kurtze, 1983).  One critique of the 
EDSS is that is lacks sensitivity towards mild changes in function or functional changes 
not related to ambulation, and has limited interrater reliability.  (Noseworthy et. al., 
1990).  
Wilksi and Tasiemski (2015) also investigated the effect of personal factors on 
self-management in MS.  Findings suggested that patients with higher educational levels 
scored higher in self-management, and women typically scored higher in self-
management than men.  “The study participants who presented with higher general self-
efficacy, long timeless perspective and perception that treatment can control progression 
of the disease tended to have higher self-management levels.” (Wilski & Tasiemski, 
2015, pg. 5). Wilski & Tasiemski (2015) found that improved self-efficacy resulted in 
increased physical activity, improved compliance in disease control and progression and 
higher self-management scores.   
 The importance of advocacy and self-advocacy has been described in the 
literature related to various patient populations.  The National Coalition for Cancer 
Survivorship (NCCS) defines self-advocacy as the “continuum that begins when an 
individual is diagnosed with cancer” and stresses the importance of patients being heavily 
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involved in decision making in regards to their treatment.  (NCCS, 2004).  The National 
MS Society defines self-advocacy as the “ability to effectively communicate an interest, 
desire, need or right – and negotiate to get it.”  (National MS Society) In addition, the 
NCCS suggests patients “arm themselves with the tools and skills necessary to feel 
comfortable about asserting yourself and communicating clearly about your cancer care 
needs.”  (NCCS, 2004).  In their guide to becoming a self-advocate, the NCCS discusses 
how disease and treatment self-education promote self-advocacy.  Additionally, the 
NCCS identifies changes in the modern healthcare system that requires patients to be 
more active as advocates, including increased healthcare costs, limited referrals, staffing 
shortages and strict reimbursement policies.  The NCCS also described self-advocacy 
benefits: decreased stress and anxiety, improved confidence, improved quality of life, 
collaboration with peers and emotional support.  There are four primary components of 
self-advocacy: information-seeking, communication, problem-solving and negotiation. 
(NCCS, 2004).  In patients with MS, there is potential for cognitive or communication 
barriers that may affect an individual’s ability to effectively advocate for themselves.   
 The National MS Society describes effective self-advocacy as awareness of 
strengths and needs, ability to identify individual goals, and understanding of legal rights 
and responsibilities.  In addition, the National MS Society describes effective practices 
for self-advocacy as situational needs assessment, consideration of ideal solutions, 
identifying assistance and using an organized approach.  In these practices, there may be 
limitations for patients with MS because of psychological and cognitive impairments.  
Cognitive impairments that may affect patients with MS include short term memory 
problems, difficulty with information processing, impaired attention and impaired 
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executive functions.  Prevalent psychological factors affecting patients with MS include 
depression, anxiety, grieving, coping issues and emotional problems.   
 Brashers et. al. (1992; 1999) described three critical components of self-advocacy 
in patient with HIV: self-education, increased assertiveness, and mindful nonadherence.  
Mindful nonadherence refers to the ability of a patient to make responsible decisions 
when providers’ recommendations are not followed and to reject a proposed treatment or 
treatment protocols outlined by the physician.  Brashers et. al. found that patients that are 
better informed about diagnosis are more likely to be compliant with treatments, which 
can impact their long-term quality of life.  They also found that assertive patients obtain 
more information about their diagnosis and are therefore more involved in healthcare 
decision-making.    
Brashers et. al. (2009) designed and compared the Patient Self-Advocacy Scale 
(PSAS) in patients with HIV (n=174) compared to healthy controls (n=218) and assessed 
the reliability and validity of the measure. The PSAS is a patient-reported measure 
composed of 12 items on a 1 (strongly agree) to 5 (strongly disagree) Likert scale.  The 
consistency of the PSAS was studied by comparing it to the Desire for Control Scale, the 
Health Opinion Survey Instrument (HOSI), the Desire for Autonomy Scale and the 
Health Locus of Control Scale.  Reliabilities for the Desire for Control Scale were 
established by Reed (1989) and Smith et. al. (1984).  The HOSI measures preferences for 
information seeking and behavioral involvement and reliability was established by Krantz 
et. al. (1980).  Reliability for the Desire for Autonomy Scale was determined to be .78 in 
work completed by Ende et. al. (1989).   The Health Locus of Control Scale measures 
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internal or external locus of control and reliabilities were reported by Dahnke et. al. 
(1994).   
The findings of these studies concluded that the PSAS is reliable and valid for 
measuring patient involvement in decision-making related to healthcare needs.  Authors 
concluded that the importance of measuring self-advocacy is related to “increased 
healthcare participation and increased likelihood of nonadherence.” (Brashers, 2009).   
 Pickett et. al. (2012) studied educational offerings in the mental health sector to 
determine the effectiveness of an 8-week peer-led program, The Building Recovery of 
Individual Dreams and Goals (BRIDGES).   This research cited the work of Brashers et. 
al. (1995) that described patients who lacked knowledge about their diagnosis were less 
likely to discuss their needs with healthcare providers and that many feel is it not 
appropriate to ask questions or challenge their providers. The goal of BRIDGES was to 
“empower mental health consumers by providing them with basic education about the 
etiology and treatment of mental illness, self-help skills and recovery principles, and peer 
support.” (Picket et. al. 2012, pg. 421).  This eight-site study had 428 patients with 
mental illness complete interviews prior to, at the conclusion and 6 months after the 
BRIDGES program.  The BRIDGES program was taught in multiple formats including 
lecture, group participation and group discussion.  The participants completed the 28-
item Empowerment Scale and an adapted version of the PSAS.  (Brasher, et.al, 2009).  
Excellent reliability and validity of the Empowerment Scale were established by Rogers 
et. al. (2010).  BRIDGES participants increased overall empowerment and 
empowerment-self-esteem and self-advocacy, specifically assertiveness scores when 
compared to the control group.  Self-efficacy referred to the individual’s confidence in 
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ability to control the environment, self-advocacy is the ability to represent and express 
needs and wants.  Self-esteem reflected a belief about one’s own worth.  These three 
attributes work together in effective self-management.  At the 6-month follow-up 
interview scores on empowerment and self-advocacy were maintained and showed the 
lasting impact of this educational program. Limitations of the study are the lack of 
observed participant involvement and peer and group leader interaction.   
Cognitive Load Theory 
The cognitive load theory has become one of the most significant areas of 
educational research over the past two decades with a significant amount of literature 
developed since first described.  (Paas et. al. 2010).  The cognitive load theory describes 
situations in which learners are overwhelmed processing large amounts of information.  
The basis of cognitive load theory is that long term memory appears to be unlimited, 
whereas short term (or working memory) has limitations in both capacity and duration of 
time in which information can be stored.  Long term memory is easily accessed and 
required to build on with new information.  For learning to occur, working and long term 
memory must work together.  
Working memory has the primary function of processing new information before 
it can be translated into the long-term memory.  The estimated capacity for working 
memory is 4 +/- 1 elements and the duration of storage of information is about 30 
seconds.  (Cowan, 2001).  Information that is not stored or practiced within that 30-
second timeframe is not transferred to long-term memory.  However, the limits of 
working memory are resolved when dealing with familiar information as compared to 
brand new information.   
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The cognitive load theory was initially described to understand the limitations of 
learners’ acquisition of new information.  One critical component of the theory is that 
instructors cannot overload or overwhelm the working memory, otherwise it fails to 
accept new information and new learning cannot occur.  (Paas, 2010).  There are three 
essential components of the cognitive load theory: intrinsic load, extraneous load and 
germane load.  Intrinsic loads are related to the complexity of the information to be 
learned.  Extraneous load are caused by poorly designed educational programming, and 
germane load is the load of working memory that can handle intrinsic information.  (Paas, 
2010).  
Another important component of the cognitive load theory is knowledge or 
information can be borrowed or learned from other people instead of always relying on 
personal experiences to create learning.  The degree to which an individual attends to an 
educational task is highly associated with the structure of educational delivery.  (Paas, 
2010).  Therefore, the design of delivery for educational programming must always be 
carefully considered.   
Many researchers have identified potential strategies to manage the three aspects 
of cognitive load theory in attempt to improve working memory and overall learning.  
Instructional techniques focused on examining examples instead of active problem 
solving allows learners to function more in working memory and relate this information 
to known information within the long-term memory.  Further recommendations include 
limiting intrinsic loads, which can potentially result in rapid overload of the working 
memory.  Management of intrinsic load can be accomplished by initiating education with 
simple tasks and building from those.  (Paas, 2010).     
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Coping, Cognitive and Psychological Impairments in MS 
 In a study of 140 patients with MS using standardized mental health measures as  
defined by the DSM-IV, several common psychological diagnoses were identified.  
(Korostil, 2007).  Anxiety was identified in 35.7% and generalized anxiety disorder was 
found in 18.6% of patients, with greater risk found in females and individuals with a 
history of depression.  (Korostill, 2007).  The work of Korostil and Feistein (2007) 
indicates that although psychological impairment is common in MS, these diagnoses are 
often overlooked by neurologists and go untreated, suggesting that many patients may be 
dealing with psychological dysfunction in addition to the recent diagnosis of a 
progressive neurological condition.  
The work of Chwastiak et. al. (2002)  investigated a large sample of people with 
MS and found 41.8% of patients had evidence of depression.  Furthermore, the risk of 
depression across the lifespan was estimated to be 50%.  (Chwastiak et. al., 2002).  When 
comparing these findings to other chronic medical conditions including asthma, diabetes 
and epilepsy, the incidence of depressive diagnoses are more common in MS.  (Kern, 
2009).   
Wineman et. al. (1994) studied 433 patients with MS and 257 patients with spinal 
cord injury (SCI) to evaluate coping behaviors specifically related to an individual’s 
uncertainty about an illness and ability to cope with some degree of uncertainty.  In this 
study, two factors of coping were identified: the emotion-focused coping (EFC) 
behaviors and the problem-focused coping (PFC) behaviors.  (Wineman, 1994).  Previous 
research by Folkman and Lazarus (1980) determined that EFC behaviors are more often 
used health-related stress, and PFC behaviors are more likely to be associated with work 
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stress.  (Folkman & Lazarus, 1980).  Patient vulnerability was a critical variable 
identified in the literature.  Without vulnerability, there were significant differences 
found in the types of coping (EFC vs. PFC) used by patients.  (Wineman et. al. 1994)  
Their research found that patients employ different types of coping when different types 
of situations occur, thus defining the need to teach multiple coping strategies to patients.  
Wineman et. al. states that “Clinicians need to be aware that under conditions of high 
illness uncertainty and appraisals of danger, the individual is at risk for negative 
emotional outcomes.  (Wineman et. al., 1994, pg. 193).  Illness uncertainty might be 
higher, if not at a peak, in patients that have recently been diagnosed with a disorder such 
as MS.  
Sadovnick et. al. reported the incidence of depression in patients with MS to be 
about 50%.  Depression can be linked to cognitive impairments such as problems with 
attention, reasoning, executive functions, memory or judgment.  Another study estimated 
the incidence of these cognitive impairments to be as high as 60-65%.  (Polman, et. al. 
2006).  However, there is not clear research to establish the specific cause of depression 
in patients.  (Lynch, 2001).  Lynch (2001) used a sample population of 188 patients with 
MS to measure psychological function using the following tests: Self-Rating Depression 
Scale (SDS), The Ways of Coping (WOC), the Hope Scale (HS) and the Uncertainty of 
Illness Scale (UIS).  These results differed from a study by Mohr (1997) by noting 
insufficient findings linking coping as a intervening variable between disability and 
depression. Mohr (1997) found that patients with high impairment levels also had higher 
scores for depression, escape-avoidance coping and problem solving, while Lynch (2001) 
found correlations between impairment groups to be more similar.  Lynch et. al. also 
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reported that depression in patients with MS was not necessarily related to an individual’s 
disability status, hypothesizing that patients of all levels of functionality are likely to 
experience depression.  (Lynch, 2001).  The biggest limitation of the research performed 
by Lynch et. al. is that it failed to define coping as a variable of depression and disability, 
which differs from the research by Mohr et. al.  (Lynch, 2001). 
 Many studies have described the relationship between level of disability and 
incidence of depression. Mohr et. al. (1997) surveyed 91 patients with MS on various 
mental health measures, including depression using the Beck Depression Inventory, 
coping using the Ways of Coping Inventory (WOCI), and level of neurological 
impairments using the Expanded Disability Status Scale (EDSS).  Participants were 
divided into groups based on level of impairment according to EDSS scale as determined 
by a neurologist.  In this correlational analysis there were two possible outcomes to 
consider.  The first model considered coping as a response to depression.  In this model, 
treatment for depression may be indicated, as increased levels of neurologic impairment 
appears to produce depression.  Therefore, treating the depression may allow for 
improved ability to utilize coping behaviors.  An alternative hypothesis suggested that 
depression is a response to coping.  In this example, “increasing neurologic impairment 
reduces one’s adaptive coping abilities which results in a greater level of depression.”  
(Mohr, 1997).  For these individuals, treatment should likely focus on improving adaptive 
coping skills to decrease or manage depression.  However, the authors suggest that these 
examples are not mutually exclusive, and that coping skills may affect psychological 
function and vice versa.  Mohr also reported that patients with higher EDSS scores 
(defined as greater than 6.5) had increased prevalence of depression and utilized more 
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avoidance behaviors in coping with their disease.  Patients with EDSS scores less than 
7.0 were associated with a lower prevalence of depression, but used more problem-
centered strategies to cope with their diagnosis and disease progression.  There were two 
significant limitations of this research: the lack of information on patient cognitive status 
and a low (46%) response rate.  Without prior knowledge of cognitive status, it would be 
difficult to determine whether those impairments are associated with depression and 
coping. The authors also recommend use of a depression-screening tool such as the Beck 
Depression Inventory, and noted that although providers tend to be aware of 
psychological problems in this patient population, early recognition was important in 
treatment.  The significant of this research was that it suggested a correlation between 
significance of neurologic impairment and risk of depression.  It also reported that 
patients with depression who are more advanced in their disease process are more likely 
to utilize maladaptive coping behaviors.  (Mohr, 1997).   
There is limited research that has specifically looked at psychological factors 
early on in the disease processes.  Kern et. al. (2009) considered this time frame as being 
critical in terms of psychological issues affecting quality of life.  In this study, 
psychological stress affecting health-related quality of life within the first three years 
since diagnosis of MS was studied.  (Kern, et. al., 2009).  Patients with MS were 
interviewed at 6-month follow-up appointments and EDSS scores were updated.  Surveys 
completed during the interview included the Symptoms Checklist-90-Revised (German 
version) which is a self-reported measure to assess psychological distress in the following 
areas: obsessive-compulsiveness, interpersonal sensitivity, phobic anxiety, somatization, 
depression, anxiety, hostility, paranoid ideation and psychoticism.  Participants also 
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completed the Functional Assessment of Multiple Sclerosis Quality of Life (FAMS) 
scale, a 59-item self-reported quality of life measure.  Kern et. al. (2009) reported on 31 
patients within 36 months since diagnosis and compared to 24 healthy individuals on 
patient-reported outcomes of psychological distress and quality of life.  Findings 
concluded that psychological distress was more prevalent in patients with MS as 
compared to healthy controls.  There was also a negative correlation between EDSS 
scores and quality of life, specifically for mobility, contentment and emotional well-
being. In patient-reported outcomes, individuals with a higher EDSS score reported lower 
quality of life.  Furthermore, patients with relapsing-remitting MS reported increased 
somatization, obsessive-compulsiveness, interpersonal sensitivity, anxiety, paranoid 
ideations and psychoticism.  Limitations of this work included the cross-sectional design 
for assessing the relationship between psychological stress, neurological disability and 
quality of life, which limited the ability to determine exact causality.  In this study, the 
sample size was on 31 patients, which makes the results less generalizable. Additionally, 
the sample size was small and potentially biased, making the results less generalizable.  
This work confirmed the presence of significant psychological distress in early-stage MS 
as compared to healthy controls.  It also defined psychological stress in early MS is not 
necessarily correlated with level of functional or neurological disability.  (Kern, 2009).  
Smith et. al. (2000) also evaluated patients in early stages of MS and reported increased 
level of distress compared to healthy controls, suggesting that psychological distress is 
not necessarily related to the neurological disability but instead may be associated with 
the social and emotional demands associated with receiving a diagnosis of MS.  (Smith, 
et. al., 2000).   
 35 
  
Some research exists that investigates illness perception in MS.  Smith et. al. 
(2000) defined the effect of psychological distress on illness perception in MS.  This 
work compared the perception of disability of a patient with MS and depression to the 
perception of disability their physician reported and compared to individuals that were 
not depresses. These researchers hypothesized that patients may have a negative 
perception of treatment effectiveness.  (Smith, 2000).      
The correlation between psychological impairment and employment status was 
been studied by Moore et. al. (2013).  Their findings concluded that individuals with MS 
who left the workforce, decreased their workload by job modification or moved to part-
time positions reported increased levels of disability when compared to individuals who 
continued with fulltime employment.  Additionally, when job changes were made, those 
individuals also reported increased levels of fatigue, increased cognitive impairments and 
more mobility issues.  (Moore, 2013).  Other patient-reported issues were described 
related to cognitive impairments such as delayed processing and memory impairments.  
(Rumrill, 2015).   
Emotional Intelligence (EI) has been defined as the “ability to manage feelings or 
emotions” and includes components such as perception, understanding and regulation of 
emotions.  (Ghajarzadeh, 2014).  In one study 166 patients with confirmed diagnoses of 
MS were compared to 100 healthy controls to evaluate the EI as a factor in MS.  Results 
showed that EI scores were significantly lower in those with MS when compared to 
healthy controls, inferring that the disease may affect the ability of individuals to regulate 
emotions.  This study also determined that EI was not significantly different in men and 
women regardless of the presence of MS.  (Ghajarzadeh, 2014).   
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Guiding Contemporary Research 
  
 The Cochrane Collaboration (2014) performed a comprehensive literature review 
on information provided to people with MS.  Over 1300 patients in 10 different studies 
from the United States, Germany, the United Kingdom, Italy, Belgium and Australia 
were included in the analysis assessing various approaches to educational delivery.  The 
age range for patients in these studies was 31-51 years old, and 60% of the participants 
were women.  The conclusion of this analysis only presents low-moderate quality 
research indicating the need for additional studies in the area of education for people with 
MS.   
 The Cochrane Collaboration (2014) reviewed four studies (524 patients) that 
looked at understanding of MS, there were significant differences in patient knowledge 
following intervention.  However, there is only moderate level research to support these 
studies based on the presence of bias.   
An additional four studies assessing decision-making in patients with MS were 
analyzed with low quality research to support claims based on bias and inconsistency.  
The research by Kopke et. al. (2009) suggested there is a significant difference in a 
patient’s ability to play an active role in decision making when provided with patient 
education.  Two studies that showed no difference in decision-making or role preference 
in patients that were educated about their disease.  (The Cochrane Collaboration, 2014).   
Five studies analyzed in The Cochrane Collaboration (2014) assessed the effects 
of education in MS on quality of life.  Two studies reported improvements in some of the 
sub-scales of the Short-Form 36 (SF36), a general scale used to assess quality of life in 
many patient populations.  Both of these studies (Ennis, 2006; O’Hara, 2002) showed 
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improvements in the mental health scale of the SF36 after providing patient education.  
However, both of these studies were low quality based on the presence of bias and 
inconsistencies as identified by the Cochrane Collaboration review.   
The last outcome group assessed in the Cochrane Collaboration (2014) reviewed 
the frequency of adverse effects related to educational programming in patients with MS.  
Six studies were analyzed, including 765 patients, and no adverse events were reported.   
Mulley et. al. described recent advances in medical interventions and the 
importance of physicians understanding all potential treatment options as well as 
associated risks, benefits or side effects.  These authors also point out the flawed 
assumption that doctors are the experts and ultimately know best in terms of diagnosis 
and treatment.  Mulley et. al. also discuss two types of diagnosis: the medical diagnosis, 
and the patient preference diagnosis, which is often silent. A preference misdiagnosis 
occurs when patients are given treatments that are not their first option, or when other 
options may not have been offered.  These misdiagnoses also occur when patients 
perceive one treatment as being superior based on the notion that “physicians know best.”  
A cross-sectional descriptive dissertation has been completed investigating the 
relationship between patient-related learned helplessness and disease status, functional 
disability, social disability and disease activity in MS.  Learned helplessness is “a 
generalized expectancy of non-contingency between response and outcome” that patients 
with chronic illness are at high risk of developing.  (McGuinness, 1995).  Learned 
helplessness has been associated with poorer health outcomes and is indirectly associated 
with impairments of cognitive function, affective health and motivation.  This 
dissertation study included 72 patients with MS in Canada who had been diagnosed for at 
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least one year and recorded the Minimum Record of Disability, Kurtzke’s Functional 
Systems and the Disability Status Scale, the Incapacity Status Scale, the Environmental 
Status Scale, the Learned Helplessness Scale and demographic data.  Patients voluntarily 
completed these scales at the time of clinic appointments, or were visited to complete the 
measures.  The study included 72 patients (50 female, 22 male), fifty percent of 
participants with at least some university education, and 34.7% that were currently 
employed.  (McGuinness, 1995). 
The research concluded that there is a statistically significant correlation between 
learned helplessness and increased social disability, employment status and between 
disease status functional disability and social disability.  The study found a weak positive 
but statistically non-significant relationship between disease status as rated on the 
Disability Status Scale and learned helplessness.  This study concluded that patients with 
MS are susceptible to learned helplessness given the chronic nature of the disease.  
However, learned helplessness is likely to decrease with disease duration, suggesting 
patients learn to cope or manage the effects of their disease over time.  Patients that are 
involved in disease management and effectively advocate for their needs may be less 
likely to experience learned helplessness, further providing support to the importance of 
promoting patient education and advocacy.  
 MS is a variable but progressive neurological condition that affects each 
individual differently, establishing the need for individualized education.  The variability 
of the disease is indicative of the uncertainty patients experience in coping with the 
diagnosis of MS.  Decision-making is a critical part of autonomy and management of MS 
and ranges from DMT to management of acute relapses and adjunctive therapies.  The 
 39 
  
increasing number of available treatment options requires additional education and 
support from healthcare providers.  There are multiple barriers to patient education in MS 
including cognitive impairments, access to education, ability to understand material, 
accuracy and timeliness of the delivery of education, and the cognitive load theory.  
There are several studies showing the importance of educational programs for patients 
and investigating the efficacy of various delivery styles.  Providing accurate, timely and 
evidence-based education to patients with MS is a critical part of autonomy and self-
management.   
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CHAPTER 3 – METHODOLOGY  
 
Introduction 
 
 In the past two decades, research has shown the effectiveness of treatment options 
for patients such as disease-modifying therapies and the benefits of a multi-disciplinary 
approach to treatment in managing multiple sclerosis (Burks, 2000.  Halper, 2010. 
Namey, 2010).  However, many patients either live in areas where access to care is 
limited or they are not provided with the appropriate information to advocate effectively 
in managing their disease.  There is no standard as to the optimal timing and amount of 
information to provide to patients after receiving a diagnosis of MS.   
 Treatment of MS includes medication management and monitoring of disease 
progression by a physician or nurse practitioner.  There is also a significant amount of 
research to indicate the benefits of a multi-disciplinary approach of services and 
education from nursing, rehab experts, social workers, nutritionists, and mental health 
practitioners and others.  Due to the wide range of clinicians involved in care, there is 
potential for education to be completed in various settings although there may be little to 
no communication between providers.  
 One of the challenges of caring for patients with MS in rural areas is the lack of 
access to specialty services.  Larger healthcare systems often have expert clinicians and 
support staff available to participate in patient education.  Here, a common educational 
model is offered to newly diagnosed patients to improve patient understanding of their 
diagnosis and be provided with strategies for disease management.   
At Norton Healthcare, an educational program- titled MS 101 is offered quarterly 
in attempt to address the educational needs of patients with a new diagnosis of MS.  The 
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diagnosing neurologist encourages patients to attend the next available course following a 
definitive diagnosis of MS.  However, depending on the timing and patient availability, 
several months or even years may pass before an individual attends this program.  In 
other cases, patients may be attending the program within the first few weeks of 
diagnosis.  In MS 101, an MS-specialist nurse navigator and a licensed marriage and 
family therapist provide the educational programming.   
Topics in MS 101 include information about the pathology, medications (disease-
modifying and adjunctive therapies), relapses vs. pseudo-relapses, signs and symptoms, 
the disability process, employment issues and an introduction of the medical and support 
teams.  The course is approximately four hours long with intermittent breaks.   
Some barriers that arise in education is patient cognitive load, (the ability to 
absorb large amounts of information), and possible cognitive impairments in patients 
with MS.  Ultimately, patient education in chronic, progressive conditions is critical and 
provides patients with the ability to empower themselves, improve their quality of life 
and ensure optimal medical management.   
Statement of the Problem 
 There are a wide variety of educational models offered to patients with MS.  This 
has led to patients either being given too much, too little or poorly timed information in 
relation to their needs.  Sweller et. al.  (1998, 2993, 2004, 2005) has shown that the 
cognitive load theory plays an important part in understanding what people can absorb 
and retain at any given time. In patients with a neurologic disease, there is also potential 
that cognition may play a role in optimal timing, amount and pedagogy of patient 
education.  This may lead to patients not understanding the information they are being 
 42 
  
presented, or not being able to process the large volume of information that is bring 
provided.   
 Self-advocacy is an important part of patient education.  Optimally, patients 
should be able to advocate for their healthcare needs and have better control of the 
disease process, which improves the quality of life.   This research study aims to provide 
guidelines to optimize educational programs developed for patient understanding, self-
advocacy, quality of life and functional outcomes.   
Research Questions 
Research Question 1: How does the timing of patient education affect self-advocacy in 
patients with MS?   
Research Question 2: How does the amount of information provided to patients with MS 
impact their self-advocacy?   
Research Question 3: What demographic information correlates with self-advocacy? 
Research Question 4:What are the optimal time frames in which diagnosis education 
should occur?  
Research Question 5: How much information can patients with a progressive neurologic 
condition absorb in the acute phase of diagnosis? 
Hypotheses 
H1 (Null): There is no relationship between the timing of education and patient self-
advocacy. 
H1 (Alternate): There is a relationship between the timing of education and patient self-
advocacy.  
H2 (Null): The amount of education has no impact on self-advocacy. 
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H2 (Alternate): The amount of education provided negatively impacts self-advocacy. 
H3 (Null): There is no correlation between demographics and patient reported self-
advocacy. 
H 3 (Alternate): There is a correlation between demographics and patient reported self-
advocacy. 
H4 (Null):  There is no correlation between timing of patient education and self-
advocacy.   
H4 (Alternate):  There is a correlation between the timing of patient education delivery 
and self-advocacy. 
H5 (Null):  There is no relationship between the amount of information provided to 
patients and reported self-advocacy. 
H5 (Alternate):  There is a relationship between the amount of information provided to 
patients and reported self-advocacy.   
Population and Sample 
 This study will use volunteers from the Norton Healthcare system neurology 
department as subjects.  All patients diagnosed with MS at Norton Healthcare have 
opportunities to attend the MS 101 courses.  Patients involved with the Norton 
Neurologic Resource center or receiving therapies at the Norton Neurosciences & Spine 
Rehabilitation Center are also encouraged to attend by therapists.  MS 101 is offered in 
May, August and November in 2016 so patients will have the opportunity to attend a 
convenient course.  All participants will be over the age of 18 at the time of diagnosis.  
The ability to recruit patients will be impacted by the number of diagnoses made in the 
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recruitment window, but the sample size goal is 30 individuals.  Typically, each MS 101 
course has about 5 attendees.  
 Eligibility criteria for this study were: (a) confirmed diagnosis of MS, (b) ability 
to sign informed consent, (c) attendance at MS 101 course at Norton Healthcare during 
the data collection period.  Only patients who do not wish to participate will be excluded.  
Patients requiring assistance will be permitted to use family, caregivers, support staff or a 
researcher to complete surveys.  
 IRB approval was obtained through the University of St. Augustine on March 31, 
2016 with permission from Norton Healthcare.  Patient confidentiality was maintained 
throughout the study in accordance with all Health Insurance Portability and 
Accountability Act (HIPAA) to protect patient privacy.  Informed consent was reviewed 
with each participant and signed prior to the start of the MS 101 program.   
 The MS 101 course is a four-hour program offered quarterly at Norton Healthcare 
for patients and families/caregivers diagnosed with MS within the past two years.  A 
nurse navigator and a licensed family and marriage therapist teach the course, each 
covering their areas of expertise.  Material to be covered in the course includes MS 
pathology and pathophysiology, symptoms, disease-modifying therapies, adjunct 
treatments, the multi-disciplinary team, relapses and pseudo relapses, coping and 
depression, and work and family issues.  An MS research coordinator visits briefly to 
introduce the research team and describe current studies, and provides contact 
information should patients wish to get involved in clinical trials.  A representative from 
the MS Society provides literature and contact information to patients.  The course is 
given to small groups with PowerPoint presentations and handouts.   
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Instrumentation 
The Patient Self-Advocacy Scale (PSAS) was selected as a self-advocacy 
outcome measure based on its extensive use in the literature for patients with cancer and 
Human-Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome 
(AIDS). The PSAS assesses assertiveness in healthcare decision-making, illness, 
treatment education and healthcare interactions.  (Brashers, 1999).  It is a patient-
completed 12-item questionnaire reported on a 5-item Likert scale ranging from strongly 
agree to strongly agree.     
Validity and reliability of the PSAS was reported by Brashers et. al. (1999) using 
a sample of 218 patients with HIV-AIDS.  Sample group 1 included 174 patients; sample 
group included 218 healthy controls recruited by convenience.  The combined sample 
was given an 89-item questionnaire that included random placement of the 12 PSAS 
items.  The PSAS scores were tested for validity by comparison with the Desire for 
Control Scale (Burger, 1992), the Health Opinion Survey Instrument (HOSI: Krantz et. 
al., 1980), the Desire for Autonomy Scale (Ende et. al., 1989) and the Health Locus of 
Control Scale (Dahnke et. al.,1994).   
Reliability for sample group 1 was 0.60 for education, 0.67 for assertiveness, 0.82 
for nonadherence and 0.78 overall, calculated using Cronbach’s alpha.  Reliability for 
sample group 2 was 0.61 for education, 0.69 for assertiveness, 0.7 for nonadherence and 
0.78 overall.  Reliability of the combined sample was reported as 0.64 for education, 0.70 
for assertiveness, 0.79 for nonadherence and 0.78 overall.   
Validity was assessed by use of construct and criterion measures, including 
patient reported participation in activist groups compared to those not involved in activist 
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groups.  Construct validity was confirmed with comparison of other measures including 
the Desire for Control Scale and HOSI.    
Additional demographic information was collected, including age, gender, race, 
marital status, household income, education level, history of previous MS education, date 
of diagnosis and occupation.  This information was collected for correlational analysis.   
Data Collection Procedures 
 As patients arrived to the MS 101 program, the primary researcher introduced 
herself, explained the project and inquired if patients were willing to participate.  It was 
explained that participation was completely voluntary.  If agreeable, the consent form 
was reviewed and signed by the participant, the researcher and a witness (staff from the 
Norton Resource Center).  Due to the small number of participants in the programs, 
consent forms were reviewed individually with each participant.  Pre-course PSAS 
surveys, demographic forms and consent forms were collected prior to the start of the 
program.  Post-course surveys were handed out at the conclusion of the program and 
immediately collected by the researcher when completed.  The researcher transported all 
research materials to a secure office at Norton Healthcare for storage.  
Procedure 
 Patients will be recruited for the MS 101 course as part of the standard of care at 
Norton Healthcare.  Patients are encouraged to attend at diagnosed and subsequent 
medical appointments with the neurologist.  Additional recruitment may occur from 
support staff in the physician practice or the Norton Neurologic Institute Rescore Center 
(NNIRC), where the MS Nurse Navigator, mental health, social and lay navigators are 
located.  Patients sign up for MS 101 course in advance by registering with the NNIRC 
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staff who run the program.  Upon arrival to the program, each individual will be asked if 
they wish to participate, and the consent will be reviewed and signed at that time.  The 
patient will complete the demographic form and the PSAS prior to the start of the 
program.  They will be asked to repeat the PSAS at the conclusion of the four-hour 
program.   Patient information will be encoded to protect patient confidentiality and for 
data analysis purposes.  Coding in Microsoft Excel will include: gender (male – 1, female 
= 2), marital status (single = 1, married = 2, divorced = 3, widowed = 4), previous MS 
education (no = 1, yes = 2), ethnicity (Caucasian =1, African American = 2, Hispanice = 
3, Other = 4),  known family members with MS (no = 1, yes = 2), formal education level 
(middle school = 1, high school graduate = 2, vocational school graduate = 3, some 
college = 4, bachelors = 5, masters = 6, doctorate = 7) , current employment status (full 
time = 1, part time = 2, unemployed = 3, retired = 4) and household income (<$25k = 1, 
$25-50k = 2, $50-100k = 3, > 4100k = 4).  PSAS items were coded for data analysis as 
follows: strongly agree = 1, somewhat agree = 2, agree = 3, somewhat disagree = 4, 
strongly disagree = 5.  All research materials will remain in the possession of a researcher 
and will be locked in a storage drawer that only the researcher has keyed access to.  The 
drawer will be contained in a locked office at Norton Healthcare.   
Data Analysis 
Data analysis will be completed using the Statistics Package for Social Sciences (SPSS).  
Means will be calculated for age, time since diagnosis and additional demographic data.  
This study is a correlational quantitative research design.  
Dependent Variables 
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 The dependent variable is what the study presumes to be affected by the 
independent variable.  In this study, the dependent variables will be 1) the patient’s 
perception of their abilities as a self-advocate; 2) the amount of information retained from 
post-diagnosis educational programs.  
Independent Variables 
 The independent variable is the component that is being manipulated by the study.  
In this instance, the independent variable is the timing and amount of education being 
provided to these patients.  Patients will be coded for data processing including male = 1, 
female = 2.  Other demographic information will be recorded including marriage status, 
previous formal education about MS, education level, family history of MS, ethnicity, 
employment, household income and occupation.  
 Descriptive statistics will be completed for mean, standard deviation, range for all 
demographic information.  When appropriate, this data will be reported in percentages.  
The P value <0.5 will be used to support alternate hypotheses.  Pearson correlation 
coefficient will be utilized to examine relationships between pre-PSAS scores and ages, 
and pre-PSAS scores and amount of formal education.  Dependent samples t-testing will 
be utilized to examine the relationship between pre and post overall scores, while also 
reporting a standard deviation and standard error.  Spearman’s rho calculations will be 
processed to assess for any correlation between education level and changes in pre versus 
post testing scores can be identified.  An additional Spearman’s rho will be calculated to 
assess and statistically significant changes between pre and post PSAS scores when 
compared with the time period since diagnosis.   
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Confounding Variables  
 The potential for a multi-center may result in various instructors, which could be a 
confounding variable.  The potential for variation in the number of patients being 
diagnosed and their ability to attend educational programs based on dates, times and 
location would be additional confounding variables.  There is potential for variation in 
instructors of the programs, and potential for varying sizes of the programs, both of 
which may be viewed as confounding variables that may affect patient-reported data.   
 Additional confounding variables would include psychosocial factors and 
individual comorbidities.  Issues such as anxiety and depression are common in 
individuals with MS and these factors might impact motivation and engagement in 
educational programming.  Support from family members could play a role in individuals 
attending or their motivation for attendance at MS 101 courses.  There is potential that 
individuals were unable to attend programming without encouragement from caregivers 
or support for transportation or other psychosocial needs.  
Ethical Issues 
 During review of the consent forms, the researcher explained that there are no 
direct benefits of participation to each patient but that the overall goal was to make 
recommendations for future educational programs.  It was also explained that the 
researcher is completing this project as a dissertation project for a doctorate in education 
at the University of St. Augustine.  The researcher disclosed that she was employed by 
Norton Healthcare as a physical therapist in the neurologic institute. There was the 
potential for participants to feel pressured to participate based on the presence of experts 
in the field and the introduction of the researcher as a member of the MS team.  It was 
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reiterated that participation in voluntary and disclosed that physicians would not be aware 
of participation to dissolve any concerns about participation affecting care.  The 
researcher also reviewed the coding procedure to protect patient identify if enrolled in the 
study.   
Limitations and Delimitations 
One potential limitation of this study is the potential sample size.  Subjects will be 
recruited through the neurology department, but will rely on the number of diagnoses 
made during the time frame for data collection.  Other limitations include the location 
and times of the educational programs, which may not be accessible or convenient to all 
potential subjects.  If follow-up data is to be collected, there is potential that individual 
could relocate, leave the practice or choose not to participate in this portion of the study 
and would therefore limit long-term data collection.  
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CHAPTER 4 - RESULTS 
 
Introduction  
The study outlined here was quantitative and utilizes primarily descriptive 
statistics with inferential statistics to make predictions about the population studied.  All 
descriptive and inferential statistics were analyzed using the Statistical Package for Social 
Sciences (SPSS, 2016).  The alpha level for rejecting the null hypothesis was established 
at the .05 probability level and all statistics reported are two-tailed unless otherwise 
specified.  Over three MS 101 courses, a total of 11 participants were enrolled in this 
study.   
Study Participants’ Demographics 
Demographic data for the eleven participants was collected to analyze 
relationships between demographics characteristics and pre- or post PSAS survey scores.  
Demographic data is reported in tables and described below.   
Table 4.1 shows the ages of participants in the MS 101 courses from May 2016 – 
November 2016.  The average age was 42.55 years, with the youngest participant being 
30 years old and the oldest at age 67.  
 
Table 4-1.  Descriptive Statistics for Age of Study Participants 
Variable    
 n M SD 
Age             11           42.55          10.17 
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 Table 4-2 shows results from demographic data regarding marital status.  Eight of 
the participants were married, two reported being single and one reported being divorced.  
Table 4-2.  Descriptive Statistics Marital Status of Study Participants 
 Frequency Percent 
Single 2 18.2 
Married 8 72.7 
Divorced 1 9.1 
Total 11 100.0 
   
 
Table 4-3 shows the number of children each participant has.  Four patients do not 
have any children, three participants have one child, two participants have two children 
and one participant has 5 children.   
 
Table 4-3.  Descriptive Statistics for Number of Children of Study Participants 
 Frequency Percent 
No Children 4 36.4 
One Child 3 27.3 
Two Children 2 18.2 
Three Children 1 9.1 
Five Children 1 9.1 
Total 11 100.0 
 
 
Table 4-4 shows that 10 of the 11 participants were Caucasian, and the other 
being African American.  
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Table 4-4.  Descriptive Statistics for Race of Study Participants 
 Frequency Percent 
Caucasian 10 90.9 
Black 1 9.1 
Total 11 100.0 
   
 
Table 4-5 reports the number of participants who have known family members 
with MS, which was one of the 11 participants or 9.1% of the sample size.  This 
information is of particular interest given the known genetic component of MS as 
previously discussed.  
 
Table 4-5.  Descriptive Statistics for Family Members with MS 
 Frequency Percent 
No 10 90.9 
Yes 1 9.1 
Total 11 100.0 
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The highest level of completed formal education was collected from each 
participant and results are shown in Table 4-6.  The goal of collecting this data was to 
correlate changes in self-advocacy and pre- and post survey results based on education 
levels.  All participants in the study had completed high school, with two completing 
some college education, three completing a bachelor’s degree, three completing a 
master’s degree and two with doctoral degrees.  
Table 4-6.  Descriptive Statistics for Level of Education of Study 
Participants 
 Frequency Percent 
HS Grad. 1 9.1 
Some College 2 18.2 
Bachelors 3 27.3 
Masters 3 27.3 
Doctorate 2 18.2 
Total 11 100.0 
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 Employment status was collected to evaluate whether or not participants were 
working at the time of the MS 101 courses and if so, employed on a full time or part time 
basis.  This is reflected in Table 4-7.  Employment status is relevant for patients with MS 
as the disease is known to affect an individual’s ability to maintain full time employment 
long term.  Of the eleven participants in this study, 10 were working full time at the time 
of participation in the MS 101 course.  One participant reported they were retired at that 
time.  
 
Table 4-7.  Descriptive Statistics for Employment Status of Study Participants 
 Frequency Percent 
Full Time 10 90.9 
Retired 1 9.1 
Total 11 100.0 
   
 
 The average household income was assessed and is reported in Table 4-8.  One 
participant (9.1%) reported the household income of less than $25,000 per year, most 
(63.6%) reported household income between $50,000-$100,000 annually, and three 
participants (27.3%) reported household income of over $100,000 per year.   
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Table 4-8.  Descriptive Statistics for Household Income of Study Participants 
 Frequency Percent 
< 25k 1 9.1 
50 – 100k 7 63.6 
> 100k 3 27.3 
Total 11 100.0 
   
 
Central Hypothesis Number One 
 
Descriptive statistics for pre- and post PSAS scores for each survey item are 
described Table 4-9.  Of interest are changes between the pre- and post survey scores on 
each item.  Increased numeric values indicate improved subject perceived ability for self-
advocacy.  Scoring of the PSAS was coded as 1 = strongly agree to 5 = strongly 
disagree).  The mean score for PSAS item 1 was 1.09 both pre and post showing that 
there was no change in scoring for that survey item.  Survey item 1 asked about the 
participant’s perceived belief that it is important to be educated on their health and 
diagnosis.  Item 2 showed an increase in mean from 1.64 pre MS 101 course to a mean 
score of 1.73 post MS 101.  This survey item asked how likely a participant is to actively 
seek our information about their health.  Increased scores here may indicate that patients 
may be slightly less likely to seek out information about their diagnosis following the MS 
101 course.  
 Item 3 on the PSAS had a mean scored of 2.18 pre course and a post course mean 
of 2.00 showing a decrease of 0.18.  This survey item asked if the patient feels they are 
more educated than the typical United States citizen about health. The decreased score 
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suggests there are slightly increased feelings of being more educated than the typical U.S. 
citizen about their health following this educational program. Item 4 had a pre course 
mean of 3.73 that decreased to 2.55 post course.  This survey item asked participants 
about their knowledge of health-related problems; the decreased score of 1.18 suggested 
an improved sense of understanding their condition.  
 Item 5 had a pre-course mean of 3.55 that decreased to 3.0 in post-course surveys.  
Survey question number 5 inquires about a participant’s assertiveness with their 
physician and perception of needs being met by their physician.  Decreased scores 
suggests that patients at the end of the MS 101 course felt slightly more likely to act with 
assertiveness during discussions with medical providers.  
 Item 6 had a pre course mean of 2.91 that decreased to 2.64 post course.  This 
survey item asked if the participant perceived that they are more or less assertive than 
most US citizens in terms of their healthcare needs. The decreased score here suggested 
that participants felt more assertive following the educational program.  
 Item 7 had a pre course mean of 3.00 and post course mean of 3.00, indicating no 
change in average scores on the survey item about the patient’s ability to make 
suggestions to their physician about their healthcare needs.   
 Item 8 had a pre course mean of 1.55 and a post course mean of 2.64 suggesting 
that participants were less likely to question physicians about recommendation they did 
not agree with following the educational program.  
 Item 9 assessed whether or not participants felt that there were good reasons not 
to follow the physician advice.  The mean score was unchanged between pre- and post 
surveys.   
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 Item 10 asked if participants felt they had a better grasp on what their needs were 
than their physician.  In pre course surveys, the mean score for this item was 3.64, which 
decreased to 3.45 in post course analysis.  The change in scores here suggests that 
patients generally felt that their awareness of their needs increased following the MS 101 
program.  
 Item 11 asked if the participant was likely to follow physician advice even if they 
did not agree with the advice. In pre course surveys, the mean score was 2.91 which 
increased to 3.64 in post course surveys. This change in score suggested that patients 
were more likely to advocate for their beliefs following the education program when in 
disagreement with their physician.   
 Item 12 asked how often participants were noncompliant with physician 
recommendations.  On pre course surveys, the mean score was 3.73 which decreased to 
3.27 in post course analysis.  This change in score suggests individuals were less likely to 
not comply with physician recommendations after the education program compared to 
previous understanding. 
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Table 4-9.  Descriptive Statistics for Pre and Post PSAS Scores 
 
 Pre PSAS Post PSAS 
   
Item n M SD n M SD 
1 11 1.09 .302 11 1.09 .302 
2 11 1.64 .809 11 1.73 .786 
3 11 2.18 .874 11 2.00 1.00 
4 11 3.73 .786 11 2.55 1.036 
5 11 3.55 1.214 11 3.00 1.265 
6 11 2.91 .944 11 2.64 .809 
7 11 3.00 .632 11 3.00 1.00 
8 11 1.55 .820 11 2.64 1.286 
9 11 3.73 1.009 11 3.73 1.191 
10 11 3.64 1.286 11 3.45 1.368 
11 11 2.91 1.221 11 3.64 1.206 
12 11 3.73 1.272 11 3.27 1.348 
Total 11 33.64 5.59 11 32.73 7.07 
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The central null hypothesis of this research project was that the differences 
between mean aggregate PSAS posts scores when compared with mean aggregate PSAS 
pre scores would show a decrease in overall scores suggesting improved self-advocacy.  
The alternative hypothesis was that post PSAS would be statistically superior. In 
conducting a paired samples t-test of the difference between pre and post measures the 
difference was not statistically significant, t (10) = .756, p = .467.  We are unable to 
reject the null hypothesis (See Figure 4-1 below). 
 
Figure 4-1.  Bar Chart Pre/Post PSAS Scores 
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Central Hypothesis Number Two  
 
It was hypothesized that the interval between time from confirming diagnosis of 
MS and receiving the MS 101 instructional intervention would be inversely, and 
statistically significantly related, to participant improvement scores in the PSAS measure.  
To test this hypothesis, subtracting participant’s post PSAS measure from their pre PSAS 
measure created a difference score (hereinafter called Pre/Post Change).  
Table 4-10 shows grouping of participants based on the time elapsed between 
confirmed diagnosis of MS and time of attending the MS 101 course.  The majority of 
participants (54.5%) had been diagnosed at least one month prior to the program, but no 
more than 3 months prior.  Two participants (18.2%) attended the program within the 
first 30 days since being diagnosed.  Two participants (18.2%) attended more than six 
months after being diagnosed.   
 
Table 4-10: Descriptive Statistics Interval from Discharge of Study 
Participants 
 Frequency Percent 
< 1 Month 2 18.2 
1-3 Months 6 54.5 
3-6 Months 1 9.1 
> Six Months 2 18.2 
Total 11 100.0 
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It is not reasonable to assume that time interval from diagnosis was normally 
distributed so a Spearman’s Rank Order correlation was performed between interval and 
the Pre/Post Change score.   
 
Figure 4-2. Scatter Plot of Relationship between Interval and Pre/Post Change Score. 
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As discerned from the correlation matrix in table 4-11, the Spearman Rho 
correlation was positive in its direction (as opposed as negative as hypothesized), 
however, this relationship was not statistically significant.   We are therefore unable to 
reject the null hypothesis that the impact of the instructional intervention was negatively 
correlated with improvement in PSAS score. 
 
Table 4-11: Spearman rho Correlation between Interval from Diagnosis 
and Pre/Post Change Score 
 Interval From 
Dx 
Pre/Post Change Score 
Interval from 
Dx 
1.00 .250 
Sig. (2-tailed)  .229 
N  11 
 
Secondary Analysis 
 
Table 4-12: Pearson Correlation between Pre Score Total and Age 
 Pre Score Total Age 
Pre Score Total 1.00 -.107 
Sig. (2-tailed)  .754 
N  11 
 
 
Table 4-12 shows a Pearson Correlation between the total PSAS score from pre-
course and age.  The Pearson Correlation was -.107 suggesting no correlation between 
these items.  
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Table 4-13: Spearman rho Correlation between Pre Score Total and 
Education 
 Pre Score Total Education 
Pre Score Total 1.00 .061 
Sig. (2-tailed)  .859 
N  11 
 
Table 4-13 compared pre-course PSAS scores with the amount of participant 
education level.  The Spearman’s rho correlation coefficient here was .061 showing no 
significant correlation.  In table 4-14 the Spearman rho correlation between post-course 
PSAS totals of 0.187 showed no education level correlation.  
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CHAPTER 5 – CONCLUSIONS AND RECOMMENDATIONS  
 
Gallien et. a. (2014) discussed the importance of a collaborative approach to the 
treatment of MS.  The MS 101 courses provided in this report reinforced this by 
presenting the multidisciplinary team and providing education about the role of each team 
member.  The collaborative approach was further promoted by the co-teaching of the MS 
101 course by a registered nurse who specializes in the treatment of individuals with MS 
and a licensed clinical social worker (LCSW) who is part of the MS team.  One outcome 
of Gallien’s research was the importance of educating patients on each provider’s role in 
care to better facilitate the relationship between patients and each member of their care 
team.  As part of the information in the MS 101 course, the entire multidisciplinary team 
was introduced to patients and their roles defined.  Handouts were provided with pictures 
and contact information of providers to assist with patient communication needs. 
Multiple researchers including Bishop and Frain (2007, 2011), Fraser (2009) and 
Holman (2004) have discussed the effectiveness of educational programs in management 
and treatment compliance with progressive conditions.  These researchers also noted that 
patient education near the time of diagnosis is a critical component in assisting patients in 
becoming active participants in their care and decision-making related to their care.  The 
work of these researchers coincides with the goals of this study, which were to identify 
optimal timing for delivery of information given the known importance of education.  
Bishop and Frain (2007, 2011) identified five components of MS-specific self-
management abilities.  One of these components, treatment adherence and barriers was 
assessed in PSAS item number 12 which determined how frequently patients were likely 
to not comply with physician recommendations.  Pre-course average scores were 3.73 
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which decreased to 3.27.  Although not a statistically significant change, it suggested a 
trend that patients were likely to comply with physician’s recommendations.  PSAS item 
number 11 is also relevant to this question.  Here, participants were asked how likely they 
were to advocate for their beliefs or question their provider if they did not agree with 
recommendations that were made.  Pre-course averages of 2.91 increased to 3.64 post-
MS 101 courses.  This trend suggests that following formal education, patients were more 
likely to advocate for their beliefs or to question the provider when in doubt about the 
care that was recommended.  Although not a statistically different change, this trend 
again suggests that patients may be more likely to advocate for themselves once educated 
about their diagnosis.  
Bishop & Frain’s work also addressed understanding and active learning about 
medical conditions, which was also a part of this study.  All participants voluntarily 
elected to attend MS 101 with the goal of better understanding and learning more about 
the condition. Two aspects that were not measured in this study was competency or 
retention of the information presented.  Further research should identify the patient’s 
baseline knowledge of MS, and compare to post MS 101 knowledge and retention over 
an extended time period.  Formal assessment of pre/post understanding of MS would 
ensure type and quantity of information that is gained from one course.   
An additional component of Bishop & Frain’s (2007, 2011) work was the level of 
active participation in decision-making.  This was assessed in PSAS item number 5 
which measured assertiveness when discussing care with providers.  The average pre-
course score of 3.55 decreased to 3.0 following education.  This trend implied that 
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patients were more likely to be assertive after educational programming, a finding that is 
supportive of research of Bishop and Frain.   
The last component of Bishop & Frain’s (2007, 2011) five components of self-
management was how patients managed the impact MS has had on their life.  Although 
not objectively measured, this topic was covered in the MS 101 course.  The LCSW 
addressed disclosing the diagnosis to friends and family and issues with employment in 
the MS 101 course.  There were no specific measures obtained in this study to assess how 
MS has impacted the lives of patients, offering an opportunity for future research.  
Bishop et. al. (2009) identified that most patients sought information from was the 
internet, books, physicians, support groups and MS societies.  In this study, no patients 
reported receiving any prior MS education, which implied that they may prefer this 
course which was led by an MS-certified nurse and licensed clinical social worker who 
practiced as a mental health therapist for patients with MS, which is in agreement with 
Bishop’s work.  However, additional questioning about previous independent education 
about MS might be helpful to determine how much patients had read online or researched 
on their own.   
Somerset (2002) had reported previously that patients preferred to receive 
education from MS-certified nurses.  This study found that attendance at MS 101 courses 
supported the idea that patients at Norton Healthcare also preferred to receive education 
from MS-certified nurses.  Patients had elected to attend this course and many had waited 
a few months in order for this to be their primary means of education.  Patients at Norton 
Healthcare are informed about the MS 101 course by the neurologist or the Norton 
Resource Center which sponsors the educational programs. Matti et. al. (2010) described 
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the preference of patients for education from neurologists or specially trained staff 
instead of primary care physicians or lay people.  
Forbes et. al. (2007) described that patient needs for education are the greatest 
early in the disease process.  Most patients (73%) attended MS 101 within the first three 
months since diagnosis, which aligned with Forbes’s recommendations.  However, the 
MS 101 course is only offered quarterly, which can limit the timeframe in which patients 
can attend.  
Box et. al (2003) evaluated the prevalence of patient education occurring within 
the first year since diagnosis of MS, and reported an increase from 14% in 1974 to 72% 
in 2000.  This study aligned with the work of Box et. al. with 100% of the participants  
obtaining formal education related to their condition within one year of a formal 
diagnosis.  In addition, the MS 101 course covered information about MS symptoms, 
medication options, disease course and allowed for interaction with an MS certified 
nurse.  These were the most commonly reported areas of patient education need as by 
Box (2003).  However, in contrast to the work by Box, the MS 101 program had a 
considerable amount of information regarding symptom management, which Box (2003) 
had reported as being the biggest gap in patient education.  
One of the major goals of this research was to establish the optimal timeframe in 
which formal patient education should be completed for individuals newly diagnosed 
with MS to optimize their ability to self-advocate.  This goal was supported by the work 
of Chiovetti (2006) who reported on the critical need for patient education to occur at an 
appropriate time and at the appropriate levels.  However, we were unable to identify what 
the critical timeframe is for this patient population.  In addition, without retention tests, 
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we cannot speak to the amount of information that was provided in the MS 101 
programming.  Chiovetti (2006) also described the importance of health literacy and 
ensuring all patient education materials were written to a level that all patients could 
understand.  Although there was no formal assessment of this, MS 101 course organizers 
reported that course materials were developed at a third grade reading level.  
 Chiovetti (2006) has documented that formal patient education should occur in a 
friendly environment.  The MS 101 course took place in a large conference room with 
space available for snacks and breaks as needed.  The room was setup to promote 
discussion and involvement of all participants.  An additional recommendation made by 
Chiovetti was for materials to be provided in written and verbal forms, through the use of 
Powerpoint and printed handouts.  
 Broadbent et. al. (2006) found that women with MS had higher reported self-
management skills than men, a result was not found to be significant in this study.  
Broadbent et. al. (2006) and Wilski and Tasiemski (2015) each reported that individuals 
with higher education levels scored higher on self-management questionnaires. This 
study did not find a correlation between education levels and PSAS scores. (See Table 4-
13).   
Key Findings 
 A major hypothesis of this study was that time since diagnosis of MS and patient 
reported self-advocacy would be correlated.  We hypothesized that there would be an 
ideal timeframe in which patient education should be provided to maximize self-
advocacy.  The findings of this study did not support these hypotheses.  However, there 
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were some important trends that were noted that offer insight to the value of this 
educational program and highlight further needs for education and research in this area.  
 PSAS item number 2 explores the likelihood of a patient seeking out information 
on the diagnosis.  The mean score increased from 1.64 pre-course to 1.72 post-course.  
Although this change was not statistically significant, it suggested that patients may be 
less likely to seek out additional information, which may indicate the MS 110 course 
made he feel they were adequately informed about their diagnosis at that time.  
 PSAS item number 3 decreased from 2.18 to 2.00 between pre and post-course 
surveys.  This item assessed if patients felt they were more educated than the typical US 
citizen about their own health.  A decrease of 0.18 was not statistically significant but 
suggested patients believed their education level had improved and provided additional 
support of the value of patient education.  
 One of the more meaningful changes reported here was PSAS item number 4 that 
decreased from 3.73 to 2.55 for an overall change of 1.18.  This change suggested that 
patients understood their condition better following formal education.  A better 
understanding of the condition following patient education might imply the importance of 
offering educational programs early in the disease process.  
 Item number 11 was also an importance factor in this study as it assessed how 
likely patients were to advocate for beliefs after receiving formal education.  A decrease 
in PSAS scores from 3.64 to 3.45 was not statistically significant but again suggests that 
educational programs increased self-advocacy and empowered patients to act on their 
own behalf in regards to medical care.   
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 The last PSAS item that supported this hypothesis was number 12 which 
determined how likely patients were to not comply with physician recommendations.  A 
decrease in mean scores from 3.73 to 3.27 was noted here which indicated that patients 
were more likely to be compliant.  This suggested that education offered insight into the 
condition, treatment options and was likely to promote patient compliance.  
 An addition major hypothesis of this study was that patient educational attainment 
and reported self-advocacy would be correlated.  Individual education level was 
compared with the change in PSAS scores; the Spearman rho correlation was .061 
showing no correlation between patient formal education and PSAS scores.  
 Another hypothesis of this study was that the amount of education provided could 
impact self-advocacy scores.  This data was not objectively collected in hopes of patients 
using feedback forms or discussion to offer insight in this area.  However, patients did 
not provide any meaningful feedback as to the length of the program or content that 
offered strong recommendations into potential program modification.   
 This research suggests the importance of patient education and the need to ensure 
timely delivery of education to maximize self-advocacy.  The trend in averages between 
pre and post-course PSAS scores suggests that patient education was successful in 
allowing patients to better understand their diagnosis and various treatment options 
related to their condition.   Another important trend in scores was increased likeliness of 
seeking out information related to their condition, which suggests that patients had a 
better understanding on how to seek out information and about resources available to 
them.  PSAS item number 8 showed that after the MS 101 course individuals were less 
likely to question physicians when they did not agree with a recommendation.  This 
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suggests that patients have improved trust in their healthcare team following education 
provided by members of the comprehensive MS team. PSAS item 10 showed a trend 
towards individuals feeling that they had better awareness of their needs following and 
MS 101 program.  PSAS item number 11 showed a trend towards patients reporting that 
they were more likely to advocate for their healthcare needs following an educational 
program.  All of these trends support the value of patient education and the need for 
patient education to be readily available to patients. This information is valuable to the 
funding sources that support programs such as MS 101 in continuing to provide this 
programming to maximize patient potential.  An additional value of the MS 101 program 
is the experience itself where individuals are able to interact with others with their 
condition and develop a bond with healthcare providers to help them feel more supported.   
 
Limitations of the Study 
 There were several limitations to this study, the most prominent of which was the 
small number of participants resulting in low power for statistical analysis.  The total 
enrollment for the study was 11 participants.  Every individual approached about the 
study agreed to participate, so none were excluded.  One potential reason for low 
enrollment was the relatively short duration of data collection, which spanned over a nine 
month period but with only three offerings.   In addition to the limited course offerings, 
the timing of the courses may not have been reasonable for patients who work as the 
general timeframe was 1pm-5pm on a weekday.   
 Another limitation of this study was it only evaluated the immediate impact of the 
educational program without long-term follow-up to assess the program effectiveness on 
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patient self-advocacy or educational needs which would be essential to assess the 
cognitive load theory implications on retention of large amounts of information.   In 
future studies, a baseline evaluation of individual’s knowledge of MS prior to the MS 101 
courses should be used and compared to post-test values to assess program material 
comprehension.  Further research should also include an assessment of knowledge 
retention.  According to the cognitive load theory, learners can become overwhelmed 
when trying to process and transfer large amounts of information from working memory 
to long term memory.  An immediate post-test and a retention test would allow 
researchers to evaluate components of cognitive load theory specific to this patient 
population.   
 This study evaluated only one educational program at one comprehensive MS 
center, providing limited ability to apply to other such programs and threatening external 
validity. Other centers that use different strategies for patient education may not be able 
to generalize the findings of this study to standardize educational procedures.   
  Factors affecting internal validity were also present in this study.  There was no 
baseline assessment done to evaluate prior knowledge of MS.  Patient intake forms 
assessed prior MS education with no patients reporting previous understanding or 
knowledge.  However, it is likely that some patients had sought to educate themselves 
about the diagnosis through other means.  There is also the potential that some patients 
could have a medical background and/or have previous knowledge of MS through friends 
or relatives with the same diagnosis.   
 An additional threat to internal validity was the potential for psychological 
changes within the patient during the study.  Although pre and post measures were 
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collected on the same day, there may have been experiences during the course that could 
have affected patient-reported outcomes.  For example, some patients may have been 
motivated or discouraged by hearing about other people’s experiences, which could have 
impacted their self-advocacy scores.  
 The testing component could have some impact on study validity as well.  The 
same measure (PSAS) was used as a pre-test and post-test, but the potential for fatigue 
exists.  Patients may have become fatigued during the four-hour course or had external 
factors that caused them to answer quickly or put less effort into their responses in an 
effort to complete the study and leave sooner.   
 This study lacked randomization; a sample of convenience was used based on 
patients who had elected to attend the MS 101 courses that occurred during the data 
collection period.  All patients were given the option to participate after consent was 
given and educated about the role of the researcher.  There is a possibility that patients 
felt obligated to agree to participate since they were approached directly by the 
researcher, who was also identified as a member of the MS treatment team.  Patients may 
have perceived this situation as pressure to participate, although during the consent 
process, they were assured that participation was voluntary and confidential.   
 A potential impact on applicability of this study is that only the MS 101 course at 
Norton Healthcare was evaluated, which limits the generalizability of the findings to only 
this educational program.  The current model for patient education at Norton Healthcare 
for other progressive neurologic conditions such as Parkinson’s disease is similar to MS 
101.  Other MS centers have varying methods of patient education – most centers provide 
education online, and some centers provide shared medical appointments where patients 
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interact in small groups with a provider to be educated on their diagnosis.  There is 
limited research supporting the efficacy of these types of educational programs.  
 
Recommendations for future research 
 
 As a result of this research study, many suggestions for future research can be 
made.  This research did not specifically look at the length of the MS 101 course and the 
potential implications of the cognitive load theory.  Previous researchers hypothesized 
that an educational program that is too long or that provides too much information may 
affect the learner’s ability to comprehend or retain the material.  Some means of 
evaluating and making recommendations for the ideal length of educational programs 
would be useful in planning future programming and optimizing the information 
provided to patients.  Cognitive load theory refers to an individual’s ability to absorb new 
information and recognize individual differences, but a large study could make some 
general recommendations in regards to program length.  Ideally, a comparative study that 
collects feedback from two MS 101 programs, one of shorter length and one more 
comprehensive and then evaluates comprehension, retention and patient feedback on the 
volume of information would be helpful.  That data should be compared with post-course 
comprehension and retention scores to objectively document differences.  
 Future studies in this area should also consider a baseline cognitive assessment, 
specifically when interested in the cognitive load theory or retention of education.  
Depending on the size and location of MS lesions, memory and cognitive function could 
be impaired even within the first year of diagnosis, which would impact an individual’s 
ability to comprehend and retain information provided in MS 101 courses and could 
further impact their PSAS scores.  Additionally, patients that have difficulty 
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understanding or retaining information may become frustrated with the program and this 
could impact PSAS scoring.  One method to assess this would be to provide a baseline 
cognitive assessment and evaluate for any correlation between scores on these 
assessments and self-reported PSAS scores. 
 Additionally, supplementary subjective feedback from patients on the content, 
length and presenters of the program should be gathered.  A general course review was 
provided but patient comments were not a part of that review.  
 This study assessed only one center’s approach to educating patients that are 
newly diagnosed with MS.  In future studies, a comparative analysis that studies at 
different models would be helpful.   This could lead to standardized formal education 
programs and provide a framework for newer MS programs on optimal formatting for 
patient education.  
 A significant portion of the MS 101 course addressed the impact of MS on the 
lpatients’ lives, disclosure of the diagnosis to family and friends, and future barriers, 
including coping skills, anxiety, depression, missed work and disability.  However, there 
was no objective measure such as a quality of life tool taken during this study to assess 
how MS had impacted the lives of the patients that participated.  In future research, this 
would be a valuable tool to track the impact at the time of diagnosis and as the disease 
progresses.  
   
 One major goal of this study was to examine the MS 101 program and determine 
the relationship between time since diagnosis and perceived self-advocacy and 
recommend an ideal timeframe in which patient education should be initiated and 
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completed.  Future studies may consider motivation as a correlate between attendance 
and self-advocacy.  Patients may have attended programs based on their own interest or 
goals or attended at the request of family members.  Patient motivation and self-advocacy 
may indeed be related.    
 A significant component of the self-advocacy questionnaire involves patient 
interactions with physicians and willingness to ask questions and interact with providers.  
Future research should consider previous interactions with physicians as a possible factor 
in self-advocacy.  Patients may have seen multiple providers through the diagnostic 
process or had other encounters with healthcare professionals that played a critical role in 
self-reported PSAS scores.  For example, a negative interaction with a past provider may 
influence patients’ ability to advocate for needs and this factor should be considered in 
further research.   
 An additional factor that should be considered is the level of family support.  
Many patients attending MS 101 were accompanied by spouses, parents or other family 
members, but this data was not formally collected.  In future studies, this may be a 
critical factor to consider.  Some individuals may rely heavily on family members during 
medical appointments, which could impact their reported self-advocacy measures.  In 
other cases, family may be less involved and place more demands on the individual to 
manage their own medical needs.  This factor may become especially important in 
individuals with cognitive impairments.   
  In this research, no specific information was collected about each individual’s 
disease, such as the type of MS (if known), number of lesions, relapses, responses to 
medications or aggressiveness of their disease.  One standardized tool for assessing the 
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level of impairment in MS is the Expanded Disability Status Scale (EDSS) which 
evaluates the level of function specific to mobility.  Obtaining this information would 
require access to medical records and physician documentation, but may offer an 
interesting area of research to determine if there are correlations between the level of 
disability and patient-reports self-advocacy.   
 Finally, another area for future research is long-term follow-up to determine is 
self-advocacy at diagnosis translated into improved outcomes or improved disease 
management.  For this research to be completed there would need to be a lengthy study 
following patients over several years, which could present challenges with research 
personnel and the ability to monitor patients for prolonged periods of time.  
Researcher Observations 
 There were several observations made by the researchers during this study that 
warrant discussion.  Although MS 101 is presented by a nurse and social worker, which 
supports the multidisciplinary approach, there would likely be great value in a brief 
discussion with a patient who has lived with MS for some time.  This would allow newly 
diagnosed individuals to learn from the experience of others they may relate better to.  
This would also allow for individuals to possibly ask questions from someone they view 
as a peer that they may not necessarily bring up with medical professionals.  
Additionally, this opportunity would likely generate some personal relationships that 
could be beneficial to individuals as they cope with their diagnosis.  
 In recommendations to Norton Healthcare, it was suggested that the MS 101 
course be decreased to three hours with challenging topics such as coping and disability 
being removed.  Through observation, I found that these difficult discussions changed the 
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energy of the course, resulted in some individuals withdrawing from discussion and 
becoming more emotional.  Since this suggestion was made, the program has been 
modified and the abbreviated MS 101 course begins in February 2017.  Additionally, I 
suggested an optional MS 102 course that could run once or twice per year specifically to 
address issues with disclosure, employment or disability.  I also suggested that providers 
strive to limit their referrals to MS 101 programs to those individuals diagnosed within 
one-year timeframes.  In one observation, I noted a patient with a more aggressive form 
of MS who had been diagnosed for several years attending the program and noted some 
changes in discussion that could be viewed as intimidating to newly diagnosed 
individuals.  
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